
### [MONDO:0005062](http://purl.obolibrary.org/obo/MONDO_0005062)
**Label:** lymphoma

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive b-cell non-Hodgkin lymphoma), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent b-cell non-Hodgkin lymphoma), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0020325](http://purl.obolibrary.org/obo/MONDO_0020325) (anaplastic large cell lymphoma), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0018908](http://purl.obolibrary.org/obo/MONDO_0018908) (non-Hodgkin lymphoma), [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759) (b-cell non-Hodgkin lymphoma), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0015817](http://purl.obolibrary.org/obo/MONDO_0015817) (aggressive primary cutaneous T-cell lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0015816](http://purl.obolibrary.org/obo/MONDO_0015816) (indolent primary cutaneous T-cell lymphoma), [MONDO:0015758](http://purl.obolibrary.org/obo/MONDO_0015758) (primary cutaneous T-cell lymphoma), [MONDO:0018897](http://purl.obolibrary.org/obo/MONDO_0018897) (primary cutaneous CD30+ T-cell lymphoproliferative disease), [MONDO:0015820](http://purl.obolibrary.org/obo/MONDO_0015820) (primary cutaneous b-cell lymphoma), [MONDO:0018898](http://purl.obolibrary.org/obo/MONDO_0018898) (primary cutaneous lymphoma), [MONDO:0015760](http://purl.obolibrary.org/obo/MONDO_0015760) (T-cell non-Hodgkin lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0015821](http://purl.obolibrary.org/obo/MONDO_0015821) (mycosis fungoides and variants), [MONDO:0017207](http://purl.obolibrary.org/obo/MONDO_0017207) (primary organ-specific lymphoma), 

**Corr. equiv. classes:** [Orphanet:178548](http://www.orpha.net/ORDO/Orphanet_178548), [Orphanet:542](http://www.orpha.net/ORDO/Orphanet_542), [Orphanet:541](http://www.orpha.net/ORDO/Orphanet_541), [Orphanet:300846](http://www.orpha.net/ORDO/Orphanet_300846), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [Orphanet:178566](http://www.orpha.net/ORDO/Orphanet_178566), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:178563](http://www.orpha.net/ORDO/Orphanet_178563), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [Orphanet:171901](http://www.orpha.net/ORDO/Orphanet_171901), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:98293](http://www.orpha.net/ORDO/Orphanet_98293), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:178551](http://www.orpha.net/ORDO/Orphanet_178551), [Orphanet:391](http://www.orpha.net/ORDO/Orphanet_391), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:171915](http://www.orpha.net/ORDO/Orphanet_171915), [Orphanet:279911](http://www.orpha.net/ORDO/Orphanet_279911), [Orphanet:547](http://www.orpha.net/ORDO/Orphanet_547), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:98841](http://www.orpha.net/ORDO/Orphanet_98841), [Orphanet:171918](http://www.orpha.net/ORDO/Orphanet_171918), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), [OMIM:236000](http://purl.obolibrary.org/obo/OMIM_236000), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0002488](http://purl.obolibrary.org/obo/HP_0002488) (Acute leukemia))) 38.99%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes))) 38.99%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count))) 38.64%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011893](http://purl.obolibrary.org/obo/HP_0011893) (Abnormal leukocyte count))) 37.97%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue))) 37.66%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 37.35%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 35.06%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 35.06%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 35.06%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 35.06%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 35.06%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 35.06%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 26.89%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 25.34%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.83%


